United Therapeutics Corporation is a publicly traded company delivering advanced pharmaceutical therapies and organ transplant technology

United Therapeutics is a biotechnology company focused on creating unique products to address the medical needs of patients with chronic illnesses.

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions.

Embrace a culture of innovation, accountability, creativity, and inclusivity at United Therapeutics. Explore our career opportunities today!

United Therapeutics offers innovative treatments for PAH, PH-ILD, and neuroblastoma. Explore our commitment to advancing care and improving lives

Access the collection of manuscripts, presentations, posters, infographics, videos, and symposia material managed by the United Therapeutics Medical Affairs team.

Learn about the United Therapeutics facilities around the world that are dedicated to creating medicines for life & supporting patients' access to therapies.

Explore the journey of United Therapeutics from its inception in 1996 to its groundbreaking work in PAH treatments & becoming a public benefit corporation

United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension, or PAH .

At United Therapeutics, our mission and vision are one. We use our enthusiasm, creativity, and persistence to innovate for the unmet medical needs of our patients and to benefit our other stakeholders.